This announcement is a separate document:
民生证券股份有限公司关于上海证券交易所《关于对江苏艾迪药业股份有限公司重大资产购买事项的问询函》之专项核查意见
Special inspection opinions on the inquiry letter regarding the significant asset purchase of Jiangsu Aidea Pharmaceutical Co., Ltd. by Shanghai Stock Exchange Securities Co., Ltd. issued by Minsheng Securities Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.